Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Testing av tilsetning av et antiangiogent medikament (bevacizumab) til cellegift (karboplatin og paclitaxel) kombinert med immunoterapi (pembrolizumab) for PMMR, TP53 -mutert endometrial kreft

18. november 2026 oppdatert av: National Cancer Institute (NCI)

En randomisert fase II/III -studie av karboplatin, paclitaxel, pembrolizumab versus karboplatin, paclitaxel, bevacizumab versus karboplatin, paclitaxel, pembrolizumab, bevacizumab i behandlingen av pmmr, tp533

This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizumab in treating patients with stage III, IVA or IVB mismatch repair protein proficient (pMMR) and TP53 mutated endometrial cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has come back after a period of improvement (recurrent). Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Adding bevacizumab to the combination of carboplatin, paclitaxel and pembrolizumab may be more effective than the usual treatment combinations of carboplatin and paclitaxel with or without pembrolizumab in treating patients with advanced or recurrent pMMR and TP53 mutated endometrial cancer.

Studieoversikt

Detaljert beskrivelse

PRIMARY OBJECTIVE:

I. To demonstrate that bevacizumab, an anti-VEGF antibody therapy, (or an anti-VEGF antibody biosimilar) in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab (the control arm) or carboplatin, paclitaxel, and bevacizumab in prolonging progression-free survival (PFS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.

SECONDARY OBJECTIVES:

I. To demonstrate that bevacizumab in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab or carboplatin, paclitaxel, and bevacizumab in prolonging overall survival (OS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.

II. To examine the impact of the addition of bevacizumab in combination with carboplatin and paclitaxel or with carboplatin, paclitaxel, and pembrolizumab on PFS and OS based on type of p53 immunohistochemistry (IHC) aberrancy (over expression/cytoplasmic expression versus null [complete absence of staining]) and mutation type.

III. To evaluate toxicity on treatment with bevacizumab when combined with carboplatin, paclitaxel, and/or pembrolizumab as assessed by Common Terminology Criteria for Adverse Events (CTCAE) version (v.)5.0.

IV. To explore the anti-tumor activity in each treatment arm as assessed by objective response rate in the subset of patients with measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM 1 (REFERENCE ARM): Patients receive paclitaxel intravenously (IV) over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional14 cycles. Additionally, patients undergo urine and blood sample collection and computed tomography (CT) or magnetic resonance imaging (MRI) throughout the study.

ARM 2 (EXPERIMENTAL TRIPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

ARM 3 (EXPERIMENTAL QUADRUPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

After completion of study treatment, patients are followed every 3 months for 2 years then every 6 months for up to 3 years.

Studietype

Intervensjonell

Registrering (Antatt)

255

Fase

  • Fase 3

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35233
        • Rekruttering
        • University of Alabama at Birmingham Cancer Center
        • Hovedetterforsker:
          • Michael D. Toboni
        • Ta kontakt med:
    • Alaska
      • Anchorage, Alaska, Forente stater, 99508
    • Arizona
      • Phoenix, Arizona, Forente stater, 85004
      • Tucson, Arizona, Forente stater, 85719
        • Rekruttering
        • Banner University Medical Center - Tucson
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marina D. Miller
      • Tucson, Arizona, Forente stater, 85719
        • Rekruttering
        • University of Arizona Cancer Center-North Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Marina D. Miller
    • Arkansas
      • Fayetteville, Arkansas, Forente stater, 72703
        • Rekruttering
        • Highlands Oncology Group - Fayetteville
        • Hovedetterforsker:
          • Joseph T. Beck
        • Ta kontakt med:
      • Little Rock, Arkansas, Forente stater, 72205
        • Rekruttering
        • University of Arkansas for Medical Sciences
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 501-686-8274
        • Hovedetterforsker:
          • Heather R. Williams
      • Rogers, Arkansas, Forente stater, 72758
        • Rekruttering
        • Highlands Oncology Group - Rogers
        • Hovedetterforsker:
          • Joseph T. Beck
        • Ta kontakt med:
      • Springdale, Arkansas, Forente stater, 72762
        • Rekruttering
        • Highlands Oncology Group
        • Hovedetterforsker:
          • Joseph T. Beck
        • Ta kontakt med:
    • California
      • Carmichael, California, Forente stater, 95608
      • Carmichael, California, Forente stater, 95608
      • Dublin, California, Forente stater, 94568
        • Rekruttering
        • Kaiser Permanente Dublin
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
      • Elk Grove, California, Forente stater, 95758
      • Fremont, California, Forente stater, 94538
        • Rekruttering
        • Kaiser Permanente-Fremont
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Fresno, California, Forente stater, 93720
        • Rekruttering
        • Kaiser Permanente Fresno Orchard Plaza
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 833-574-2273
      • Los Angeles, California, Forente stater, 90048
        • Rekruttering
        • Cedars-Sinai Medical Center
        • Hovedetterforsker:
          • Emily N. Prendergast
        • Ta kontakt med:
      • Los Angeles, California, Forente stater, 90033
        • Rekruttering
        • USC / Norris Comprehensive Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 323-865-0451
        • Hovedetterforsker:
          • Koji Matsuo
      • Los Angeles, California, Forente stater, 90033
        • Rekruttering
        • Los Angeles General Medical Center
        • Hovedetterforsker:
          • Koji Matsuo
        • Ta kontakt med:
      • Modesto, California, Forente stater, 95356
        • Rekruttering
        • Kaiser Permanente- Modesto MOB II
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
      • Oakland, California, Forente stater, 94611
        • Rekruttering
        • Kaiser Permanente-Oakland
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Palo Alto, California, Forente stater, 94304
        • Rekruttering
        • Stanford Cancer Institute Palo Alto
        • Hovedetterforsker:
          • Kristin L. Bixel
        • Ta kontakt med:
      • Rancho Mirage, California, Forente stater, 92270
        • Rekruttering
        • Eisenhower Medical Center
        • Hovedetterforsker:
          • Mark Genesen
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 760-834-3798
      • Rocklin, California, Forente stater, 95765
      • Roseville, California, Forente stater, 95661
        • Rekruttering
        • Kaiser Permanente-Roseville
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Sacramento, California, Forente stater, 95817
        • Rekruttering
        • University of California Davis Comprehensive Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 916-734-3089
        • Hovedetterforsker:
          • Nancy T. Nguyen
      • Sacramento, California, Forente stater, 95814
        • Rekruttering
        • Kaiser Permanente Downtown Commons
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: kpoct@kp.org
      • Sacramento, California, Forente stater, 95823
        • Rekruttering
        • Kaiser Permanente-South Sacramento
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Sacramento, California, Forente stater, 95816
      • San Francisco, California, Forente stater, 94115
        • Rekruttering
        • Kaiser Permanente-San Francisco
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • San Jose, California, Forente stater, 95119
        • Rekruttering
        • Kaiser Permanente-Santa Teresa-San Jose
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • San Leandro, California, Forente stater, 94577
        • Rekruttering
        • Kaiser Permanente San Leandro
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • San Rafael, California, Forente stater, 94903
        • Rekruttering
        • Kaiser San Rafael-Gallinas
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Santa Clara, California, Forente stater, 95051
        • Rekruttering
        • Kaiser Permanente Medical Center - Santa Clara
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Santa Rosa, California, Forente stater, 95403
        • Rekruttering
        • Kaiser Permanente-Santa Rosa
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • South San Francisco, California, Forente stater, 94080
        • Rekruttering
        • Kaiser Permanente-South San Francisco
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Vallejo, California, Forente stater, 94589
        • Rekruttering
        • Kaiser Permanente-Vallejo
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Walnut Creek, California, Forente stater, 94596
        • Rekruttering
        • Kaiser Permanente-Walnut Creek
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-642-4691
          • E-post: Kpoct@kp.org
      • Woodland, California, Forente stater, 95695
    • Colorado
      • Aurora, Colorado, Forente stater, 80045
        • Rekruttering
        • UCHealth University of Colorado Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Hovedetterforsker:
          • Bradley R. Corr
      • Colorado Springs, Colorado, Forente stater, 80909
        • Rekruttering
        • UCHealth Memorial Hospital Central
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 719-365-2406
        • Hovedetterforsker:
          • Bradley R. Corr
      • Colorado Springs, Colorado, Forente stater, 80920
        • Rekruttering
        • Memorial Hospital North
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 719-364-6700
        • Hovedetterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forente stater, 80524
        • Rekruttering
        • Poudre Valley Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 970-297-6150
        • Hovedetterforsker:
          • Bradley R. Corr
      • Fort Collins, Colorado, Forente stater, 80528
        • Rekruttering
        • Cancer Care and Hematology-Fort Collins
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bradley R. Corr
      • Greeley, Colorado, Forente stater, 80631
        • Rekruttering
        • UCHealth Greeley Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bradley R. Corr
      • Highlands Ranch, Colorado, Forente stater, 80129
        • Rekruttering
        • UCHealth Highlands Ranch Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 720-848-0650
        • Hovedetterforsker:
          • Bradley R. Corr
      • Loveland, Colorado, Forente stater, 80538
        • Rekruttering
        • Medical Center of the Rockies
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 970-203-7083
        • Hovedetterforsker:
          • Bradley R. Corr
    • Connecticut
      • Hartford, Connecticut, Forente stater, 06102
        • Rekruttering
        • Hartford Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 860-545-5363
        • Hovedetterforsker:
          • Amy K. Brown
      • Manchester, Connecticut, Forente stater, 06042
        • Rekruttering
        • Hartford HealthCare - Manchester
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 860-972-4700
        • Hovedetterforsker:
          • Amy K. Brown
      • New Britain, Connecticut, Forente stater, 06050
        • Rekruttering
        • The Hospital of Central Connecticut
        • Hovedetterforsker:
          • Amy K. Brown
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 860-224-5660
    • Delaware
      • Millville, Delaware, Forente stater, 19967
        • Rekruttering
        • Beebe South Coastal Health Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gregory A. Masters
      • Newark, Delaware, Forente stater, 19713
        • Rekruttering
        • Helen F Graham Cancer Center
        • Hovedetterforsker:
          • Gregory A. Masters
        • Ta kontakt med:
      • Newark, Delaware, Forente stater, 19713
        • Rekruttering
        • Medical Oncology Hematology Consultants PA
        • Hovedetterforsker:
          • Gregory A. Masters
        • Ta kontakt med:
      • Rehoboth Beach, Delaware, Forente stater, 19971
        • Rekruttering
        • Beebe Health Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gregory A. Masters
    • District of Columbia
      • Washington D.C., District of Columbia, Forente stater, 20010
        • Rekruttering
        • MedStar Washington Hospital Center
        • Hovedetterforsker:
          • Ebony R. Hoskins
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 202-877-8839
    • Florida
      • N. Venice, Florida, Forente stater, 34275
        • Rekruttering
        • Sarasota Memorial Hospital-Venice
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 941-261-9000
        • Hovedetterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forente stater, 34239
        • Rekruttering
        • Sarasota Memorial Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 941-917-2225
        • Hovedetterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forente stater, 34243
        • Rekruttering
        • Sarasota Memorial Health Care Center at University Parkway
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 941-917-6519
        • Hovedetterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forente stater, 34239
        • Rekruttering
        • Florida Cancer Specialists - Sarasota Downtown
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toni P. Kilts
      • Sarasota, Florida, Forente stater, 34239
        • Rekruttering
        • FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toni P. Kilts
      • Venice, Florida, Forente stater, 34275
        • Rekruttering
        • Florida Cancer Specialists - Venice Pinebrook
        • Ta kontakt med:
        • Hovedetterforsker:
          • Toni P. Kilts
    • Georgia
      • Atlanta, Georgia, Forente stater, 30322
        • Rekruttering
        • Emory University Hospital/Winship Cancer Institute
        • Hovedetterforsker:
          • Kristen Starbuck
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 404-778-1868
      • Atlanta, Georgia, Forente stater, 30303
        • Rekruttering
        • Grady Health System
        • Hovedetterforsker:
          • Kristen Starbuck
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 404-778-1868
      • Atlanta, Georgia, Forente stater, 30308
        • Rekruttering
        • Emory University Hospital Midtown
        • Hovedetterforsker:
          • Kristen Starbuck
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 888-946-7447
      • Augusta, Georgia, Forente stater, 30912
        • Rekruttering
        • Augusta University Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bunja J. Rungruang
      • Decatur, Georgia, Forente stater, 30033
    • Hawaii
      • Honolulu, Hawaii, Forente stater, 96826
        • Rekruttering
        • Kapiolani Medical Center for Women and Children
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-983-6090
        • Hovedetterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Queen's Cancer Cenrer - POB I
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-532-0315
        • Hovedetterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forente stater, 96813
        • Rekruttering
        • Queen's Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-545-8548
        • Hovedetterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forente stater, 96817
        • Rekruttering
        • Queen's Cancer Center - Kuakini
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-531-8521
        • Hovedetterforsker:
          • Michael E. Carney
      • Honolulu, Hawaii, Forente stater, 96819
        • Rekruttering
        • Kaiser Permanente Moanalua Medical Center
        • Hovedetterforsker:
          • Juraj Kavecansky
        • Ta kontakt med:
      • ‘Aiea, Hawaii, Forente stater, 96701
        • Rekruttering
        • Pali Momi Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-486-6000
        • Hovedetterforsker:
          • Michael E. Carney
      • ‘Aiea, Hawaii, Forente stater, 96701
        • Rekruttering
        • Queen's Cancer Center - Pearlridge
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 808-487-7447
        • Hovedetterforsker:
          • Michael E. Carney
      • ‘Ewa Beach, Hawaii, Forente stater, 96706
        • Rekruttering
        • The Queen's Medical Center - West Oahu
        • Ta kontakt med:
        • Hovedetterforsker:
          • Michael E. Carney
    • Idaho
      • Coeur d'Alene, Idaho, Forente stater, 83814
        • Rekruttering
        • Kootenai Health - Coeur d'Alene
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Post Falls, Idaho, Forente stater, 83854
        • Rekruttering
        • Kootenai Clinic Cancer Services - Post Falls
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Sandpoint, Idaho, Forente stater, 83864
        • Rekruttering
        • Kootenai Clinic Cancer Services - Sandpoint
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
    • Illinois
      • Chicago, Illinois, Forente stater, 60637
        • Rekruttering
        • University of Chicago Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alyssa Bujnak
      • Chicago, Illinois, Forente stater, 60611
        • Rekruttering
        • Northwestern University
        • Ta kontakt med:
        • Hovedetterforsker:
          • Emma Barber
      • Chicago, Illinois, Forente stater, 60612
        • Rekruttering
        • Rush MD Anderson Cancer Center
        • Hovedetterforsker:
          • Alexander C. Cohen
        • Ta kontakt med:
      • Danville, Illinois, Forente stater, 61832
        • Rekruttering
        • Carle at The Riverfront
        • Hovedetterforsker:
          • Pratima Chalasani
        • Ta kontakt med:
      • DeKalb, Illinois, Forente stater, 60115
        • Rekruttering
        • Northwestern Medicine Cancer Center Kishwaukee
        • Ta kontakt med:
        • Hovedetterforsker:
          • Emma Barber
      • Decatur, Illinois, Forente stater, 62526
        • Rekruttering
        • Cancer Care Specialists of Illinois - Decatur
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Decatur, Illinois, Forente stater, 62526
        • Rekruttering
        • Decatur Memorial Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Effingham, Illinois, Forente stater, 62401
        • Rekruttering
        • Carle Physician Group-Effingham
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pratima Chalasani
      • Evanston, Illinois, Forente stater, 60201
        • Rekruttering
        • NorthShore University HealthSystem-Evanston Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Geneva, Illinois, Forente stater, 60134
        • Rekruttering
        • Northwestern Medicine Cancer Center Delnor
        • Ta kontakt med:
        • Hovedetterforsker:
          • Emma Barber
      • Glenview, Illinois, Forente stater, 60026
        • Rekruttering
        • NorthShore University HealthSystem-Glenbrook Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Harvey, Illinois, Forente stater, 60426
        • Rekruttering
        • Ingalls Memorial Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Ivy Abraham
      • Highland Park, Illinois, Forente stater, 60035
        • Rekruttering
        • NorthShore University HealthSystem-Highland Park Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 847-570-2109
        • Hovedetterforsker:
          • Mary T. Jenkins Vogel
      • Mattoon, Illinois, Forente stater, 61938
        • Rekruttering
        • Carle Physician Group-Mattoon/Charleston
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pratima Chalasani
      • New Lenox, Illinois, Forente stater, 60451
        • Rekruttering
        • UC Comprehensive Cancer Center at Silver Cross
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alyssa Bujnak
      • Normal, Illinois, Forente stater, 61761
        • Rekruttering
        • Carle BroMenn Medical Center
        • Hovedetterforsker:
          • Pratima Chalasani
        • Ta kontakt med:
      • Normal, Illinois, Forente stater, 61761
        • Rekruttering
        • Carle Cancer Institute Normal
        • Hovedetterforsker:
          • Pratima Chalasani
        • Ta kontakt med:
      • O'Fallon, Illinois, Forente stater, 62269
        • Rekruttering
        • Cancer Care Center of O'Fallon
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • O'Fallon, Illinois, Forente stater, 62269
        • Rekruttering
        • HSHS Saint Elizabeth's Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Oak Brook, Illinois, Forente stater, 60523
      • Oak Park, Illinois, Forente stater, 60304
        • Rekruttering
        • Rush MD Anderson Cancer Center at Rush Oak Park
        • Hovedetterforsker:
          • Alexander C. Cohen
        • Ta kontakt med:
      • Orland Park, Illinois, Forente stater, 60462
        • Rekruttering
        • University of Chicago Medicine-Orland Park
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alyssa Bujnak
      • Orland Park, Illinois, Forente stater, 60462
      • Peoria, Illinois, Forente stater, 61637
        • Rekruttering
        • OSF Saint Francis Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bryan A. Faller
      • Springfield, Illinois, Forente stater, 62702
        • Rekruttering
        • Southern Illinois University School of Medicine
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 217-545-7929
      • Springfield, Illinois, Forente stater, 62702
        • Rekruttering
        • Springfield Clinic
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-444-7541
      • Springfield, Illinois, Forente stater, 62781
        • Rekruttering
        • Springfield Memorial Hospital
        • Hovedetterforsker:
          • Bryan A. Faller
        • Ta kontakt med:
      • Urbana, Illinois, Forente stater, 61801
        • Rekruttering
        • Carle Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pratima Chalasani
      • Warrenville, Illinois, Forente stater, 60555
        • Rekruttering
        • Northwestern Medicine Cancer Center Warrenville
        • Ta kontakt med:
        • Hovedetterforsker:
          • Emma Barber
    • Indiana
      • Crown Point, Indiana, Forente stater, 46307
        • Rekruttering
        • UChicago Medicine Northwest Indiana
        • Ta kontakt med:
        • Hovedetterforsker:
          • Alyssa Bujnak
      • Goshen, Indiana, Forente stater, 46526
        • Rekruttering
        • Goshen Center for Cancer Care
        • Ta kontakt med:
        • Hovedetterforsker:
          • Pamela J. Stone
      • Indianapolis, Indiana, Forente stater, 46260
        • Rekruttering
        • Ascension Saint Vincent Indianapolis Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Megan E. Buechel
      • South Bend, Indiana, Forente stater, 46601
        • Suspendert
        • Memorial Hospital of South Bend
    • Iowa
      • Ankeny, Iowa, Forente stater, 50023
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Carroll, Iowa, Forente stater, 51401
        • Rekruttering
        • Saint Anthony Regional Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Cedar Rapids, Iowa, Forente stater, 52403
        • Rekruttering
        • Mercy Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 319-365-4673
        • Hovedetterforsker:
          • Deborah W. Wilbur
      • Cedar Rapids, Iowa, Forente stater, 52403
        • Rekruttering
        • Oncology Associates at Mercy Medical Center
        • Hovedetterforsker:
          • Deborah W. Wilbur
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 319-363-2690
      • Clive, Iowa, Forente stater, 50325
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forente stater, 50314
        • Rekruttering
        • Broadlawns Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-282-2200
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forente stater, 50314
        • Rekruttering
        • Mercy Medical Center - Des Moines
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Richard L. Deming
      • Des Moines, Iowa, Forente stater, 50309
        • Rekruttering
        • Iowa Methodist Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-6727
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forente stater, 50309
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Forente stater, 50314
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
      • Fort Dodge, Iowa, Forente stater, 50501
        • Rekruttering
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • Hovedetterforsker:
          • Seema Harichand-Herdt
        • Ta kontakt med:
      • Iowa City, Iowa, Forente stater, 52242
        • Rekruttering
        • University of Iowa/Holden Comprehensive Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-237-1225
        • Hovedetterforsker:
          • David P. Bender
      • Waukee, Iowa, Forente stater, 50263
        • Rekruttering
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 515-241-3305
        • Hovedetterforsker:
          • Seema Harichand-Herdt
    • Kentucky
      • Lexington, Kentucky, Forente stater, 40536
        • Rekruttering
        • University of Kentucky/Markey Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 859-257-3379
        • Hovedetterforsker:
          • Rachel W. Miller
      • Lexington, Kentucky, Forente stater, 40503
        • Rekruttering
        • Baptist Health Lexington
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 859-260-6425
        • Hovedetterforsker:
          • Hope Cottrill
    • Louisiana
      • Marrero, Louisiana, Forente stater, 70072
        • Rekruttering
        • West Jefferson Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tara Castellano
      • Metairie, Louisiana, Forente stater, 70006
        • Rekruttering
        • East Jefferson General Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tara Castellano
      • Metairie, Louisiana, Forente stater, 70006
        • Rekruttering
        • LSU Healthcare Network / Metairie Multi-Specialty Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tara Castellano
      • New Orleans, Louisiana, Forente stater, 70112
        • Rekruttering
        • University Medical Center New Orleans
        • Ta kontakt med:
        • Hovedetterforsker:
          • Tara Castellano
    • Maine
      • Brewer, Maine, Forente stater, 04412
        • Rekruttering
        • Lafayette Family Cancer Center-EMMC
        • Hovedetterforsker:
          • Sarah J. Sinclair
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-987-3005
      • Scarborough, Maine, Forente stater, 04074
        • Rekruttering
        • MaineHealth Maine Medical Center- Scarborough
        • Hovedetterforsker:
          • Leslie S. Bradford
        • Ta kontakt med:
    • Maryland
      • Baltimore, Maryland, Forente stater, 21287
        • Rekruttering
        • Johns Hopkins University/Sidney Kimmel Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amanda N. Fader
      • Baltimore, Maryland, Forente stater, 21237
        • Rekruttering
        • MedStar Franklin Square Medical Center/Weinberg Cancer Institute
        • Hovedetterforsker:
          • Ebony R. Hoskins
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 443-777-7364
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02215
        • Rekruttering
        • Dana-Farber Cancer Institute
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 877-442-3324
        • Hovedetterforsker:
          • Susana M. Campos
      • Burlington, Massachusetts, Forente stater, 01805
      • Peabody, Massachusetts, Forente stater, 01960
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • Rekruttering
        • University of Michigan Rogel Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Zhen Ni Zhou
      • Battle Creek, Michigan, Forente stater, 49017
        • Rekruttering
        • Bronson Battle Creek
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Brighton, Michigan, Forente stater, 48114
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Brighton, Michigan, Forente stater, 48116
        • Rekruttering
        • University of Michigan - Brighton Center for Specialty Care
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-865-1125
        • Hovedetterforsker:
          • Zhen Ni Zhou
      • Canton, Michigan, Forente stater, 48188
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Chelsea, Michigan, Forente stater, 48118
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Detroit, Michigan, Forente stater, 48201
        • Rekruttering
        • Wayne State University/Karmanos Cancer Institute
        • Hovedetterforsker:
          • Radhika P. Gogoi
        • Ta kontakt med:
      • Escanaba, Michigan, Forente stater, 49829
        • Rekruttering
        • OSF Saint Francis Hospital and Medical Group
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Farmington Hills, Michigan, Forente stater, 48334
        • Rekruttering
        • Weisberg Cancer Treatment Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Radhika P. Gogoi
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Genesys Hurley Cancer Institute
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Hurley Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Flint, Michigan, Forente stater, 48503
        • Rekruttering
        • Cancer Hematology Centers - Flint
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Grand Rapids, Michigan, Forente stater, 49503
        • Rekruttering
        • Trinity Health Grand Rapids Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Grand Rapids, Michigan, Forente stater, 49503
        • Rekruttering
        • Corewell Health Grand Rapids Hospitals - Butterworth Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49007
        • Rekruttering
        • Bronson Methodist Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49007
        • Rekruttering
        • West Michigan Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Kalamazoo, Michigan, Forente stater, 49009
        • Rekruttering
        • Beacon Kalamazoo Cancer Center
        • Hovedetterforsker:
          • Kathleen Y. Butler
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 574-647-7370
      • Lansing, Michigan, Forente stater, 48912
        • Rekruttering
        • University of Michigan Health - Sparrow Lansing
        • Hovedetterforsker:
          • J. R. Liu
        • Ta kontakt med:
      • Livonia, Michigan, Forente stater, 48154
        • Rekruttering
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Manistique, Michigan, Forente stater, 49854
        • Rekruttering
        • Schoolcraft Memorial Hospital
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Muskegon, Michigan, Forente stater, 49444
        • Rekruttering
        • Trinity Health Muskegon Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Niles, Michigan, Forente stater, 49120
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Niles Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 616-391-1230
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Norton Shores, Michigan, Forente stater, 49444
        • Rekruttering
        • Cancer and Hematology Centers of Western Michigan - Norton Shores
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Pontiac, Michigan, Forente stater, 48341
        • Rekruttering
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
      • Reed City, Michigan, Forente stater, 49677
        • Rekruttering
        • Corewell Health Reed City Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forente stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Saint Joseph, Michigan, Forente stater, 49085
        • Rekruttering
        • Corewell Health Lakeland Hospitals - Saint Joseph Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Traverse City, Michigan, Forente stater, 49684
        • Rekruttering
        • Munson Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Wyoming, Michigan, Forente stater, 49519
        • Rekruttering
        • University of Michigan Health - West
        • Ta kontakt med:
        • Hovedetterforsker:
          • Kathleen Y. Butler
      • Ypsilanti, Michigan, Forente stater, 48197
        • Rekruttering
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • J. R. Liu
    • Minnesota
      • Brainerd, Minnesota, Forente stater, 56401
        • Rekruttering
        • Essentia Health Saint Joseph's Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Coon Rapids, Minnesota, Forente stater, 55433
        • Rekruttering
        • Mercy Hospital
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Deer River, Minnesota, Forente stater, 56636
        • Rekruttering
        • Essentia Health - Deer River Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Duluth, Minnesota, Forente stater, 55805
        • Rekruttering
        • Essentia Health Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Edina, Minnesota, Forente stater, 55435
        • Rekruttering
        • Fairview Southdale Hospital
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Edina, Minnesota, Forente stater, 55435
        • Rekruttering
        • Minnesota Oncology - Edina
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Hibbing, Minnesota, Forente stater, 55746
        • Rekruttering
        • Essentia Health Hibbing Clinic
        • Hovedetterforsker:
          • Bret E. Friday
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 218-786-3308
      • Minneapolis, Minnesota, Forente stater, 55407
        • Rekruttering
        • Abbott-Northwestern Hospital
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Minneapolis, Minnesota, Forente stater, 55455
        • Rekruttering
        • University of Minnesota/Masonic Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 612-624-2620
        • Hovedetterforsker:
          • Alexandra Schefter
      • Saint Louis Park, Minnesota, Forente stater, 55416
        • Rekruttering
        • Park Nicollet Clinic - Saint Louis Park
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Saint Paul, Minnesota, Forente stater, 55101
        • Rekruttering
        • Regions Hospital
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Saint Paul, Minnesota, Forente stater, 55102
        • Rekruttering
        • United Hospital
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
      • Sandstone, Minnesota, Forente stater, 55072
        • Rekruttering
        • Essentia Health Sandstone
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Virginia, Minnesota, Forente stater, 55792
        • Rekruttering
        • Essentia Health Virginia Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Woodbury, Minnesota, Forente stater, 55125
        • Rekruttering
        • Minnesota Oncology Hematology PA-Woodbury
        • Hovedetterforsker:
          • Joleen M. Hubbard
        • Ta kontakt med:
    • Missouri
      • Columbia, Missouri, Forente stater, 65212
        • Rekruttering
        • MU Health - University Hospital/Ellis Fischel Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 573-882-7440
        • Hovedetterforsker:
          • Erin R. Tuller
      • Springfield, Missouri, Forente stater, 65804
        • Rekruttering
        • Mercy Hospital Springfield
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • Springfield, Missouri, Forente stater, 65807
        • Rekruttering
        • CoxHealth South Hospital
        • Hovedetterforsker:
          • Jay W. Carlson
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 417-269-4520
      • St Louis, Missouri, Forente stater, 63110
        • Rekruttering
        • Washington University School of Medicine
        • Ta kontakt med:
        • Hovedetterforsker:
          • David G. Mutch
    • Montana
      • Anaconda, Montana, Forente stater, 59711
        • Rekruttering
        • Community Hospital of Anaconda
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Billings, Montana, Forente stater, 59101
        • Rekruttering
        • Billings Clinic Cancer Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Billings, Montana, Forente stater, 59102
        • Rekruttering
        • Saint Vincent Frontier Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-648-6274
        • Hovedetterforsker:
          • Megan Petersen
      • Billings, Montana, Forente stater, 59106
        • Rekruttering
        • Intermountain Health West End Clinic
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 406-238-6685
        • Hovedetterforsker:
          • Megan Petersen
      • Bozeman, Montana, Forente stater, 59715
        • Rekruttering
        • Bozeman Health Deaconess Hospital
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Great Falls, Montana, Forente stater, 59405
        • Rekruttering
        • Benefis Sletten Cancer Institute
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Kalispell, Montana, Forente stater, 59901
        • Rekruttering
        • Logan Health Medical Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
      • Missoula, Montana, Forente stater, 59804
        • Rekruttering
        • Community Medical Center
        • Hovedetterforsker:
          • John M. Schallenkamp
        • Ta kontakt med:
    • Nebraska
      • Bellevue, Nebraska, Forente stater, 68123
        • Rekruttering
        • Nebraska Medicine-Bellevue
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lindsey A. McAlarnen
      • Kearney, Nebraska, Forente stater, 68845
        • Rekruttering
        • Fred and Pamela Buffett Cancer Center - Kearney
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lindsey A. McAlarnen
      • Omaha, Nebraska, Forente stater, 68198
        • Rekruttering
        • University of Nebraska Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Lindsey A. McAlarnen
      • Omaha, Nebraska, Forente stater, 68114
        • Rekruttering
        • Nebraska Methodist Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 402-354-5144
        • Hovedetterforsker:
          • Brent J. Tierney
      • Omaha, Nebraska, Forente stater, 68118
        • Rekruttering
        • Nebraska Medicine-Village Pointe
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 402-559-5600
        • Hovedetterforsker:
          • Lindsey A. McAlarnen
    • Nevada
      • Las Vegas, Nevada, Forente stater, 89106
        • Rekruttering
        • Women's Cancer Center of Nevada
        • Hovedetterforsker:
          • Nicola M. Spirtos
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 702-851-4672
    • New Jersey
      • Basking Ridge, New Jersey, Forente stater, 07920
        • Rekruttering
        • Memorial Sloan Kettering Basking Ridge
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • Camden, New Jersey, Forente stater, 08103
        • Rekruttering
        • Cooper Hospital University Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 856-325-6757
        • Hovedetterforsker:
          • Courtney Griffiths
      • Hamilton, New Jersey, Forente stater, 08690
        • Rekruttering
        • The Cancer Institute of New Jersey Hamilton
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 609-631-6946
        • Hovedetterforsker:
          • Eugenia Girda
      • Jersey City, New Jersey, Forente stater, 07302
        • Rekruttering
        • Jersey City Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Eugenia Girda
      • Livingston, New Jersey, Forente stater, 07039
        • Rekruttering
        • Cooperman Barnabas Medical Center
        • Hovedetterforsker:
          • Eugenia Girda
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 973-322-5200
      • Middletown, New Jersey, Forente stater, 07748
        • Rekruttering
        • Memorial Sloan Kettering Monmouth
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • Montvale, New Jersey, Forente stater, 07645
        • Rekruttering
        • Memorial Sloan Kettering Bergen
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • New Brunswick, New Jersey, Forente stater, 08903
        • Rekruttering
        • Rutgers Cancer Institute of New Jersey
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
        • Hovedetterforsker:
          • Eugenia Girda
      • Newark, New Jersey, Forente stater, 07101
        • Rekruttering
        • Rutgers New Jersey Medical School
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 732-235-7356
        • Hovedetterforsker:
          • Eugenia Girda
      • Paramus, New Jersey, Forente stater, 07652
        • Rekruttering
        • The Valley Hospital - Luckow Pavilion
        • Hovedetterforsker:
          • Eleonora Teplinsky
        • Ta kontakt med:
      • Ridgewood, New Jersey, Forente stater, 07450
        • Rekruttering
        • Valley Health System Ridgewood Campus
        • Hovedetterforsker:
          • Eleonora Teplinsky
        • Ta kontakt med:
      • Sewell, New Jersey, Forente stater, 08080
        • Rekruttering
        • Sidney Kimmel Cancer Center Washington Township
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jessa Suhner
    • New Mexico
      • Albuquerque, New Mexico, Forente stater, 87106
        • Rekruttering
        • University of New Mexico Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amaranta D. Craig
    • New York
      • Bay Shore, New York, Forente stater, 11706
        • Rekruttering
        • Northwell Health Imbert Cancer Center
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • Commack, New York, Forente stater, 11725
        • Rekruttering
        • Memorial Sloan Kettering Commack
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • Flushing, New York, Forente stater, 11354
        • Rekruttering
        • Northwell Health Physician Partners at Flushing
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
      • Greenlawn, New York, Forente stater, 11740
        • Rekruttering
        • Northwell Health Cancer Institute at Huntington
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • Harrison, New York, Forente stater, 10604
        • Rekruttering
        • Memorial Sloan Kettering Westchester
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • Lake Success, New York, Forente stater, 11042
        • Rekruttering
        • Northwell Health/Center for Advanced Medicine
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • New York, New York, Forente stater, 10065
        • Rekruttering
        • Memorial Sloan Kettering Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • New York, New York, Forente stater, 10011
        • Rekruttering
        • Mount Sinai Chelsea
        • Hovedetterforsker:
          • Stephanie V. Blank
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-post: CCTO@mssm.edu
      • New York, New York, Forente stater, 10029
        • Rekruttering
        • Mount Sinai Hospital
        • Hovedetterforsker:
          • Stephanie V. Blank
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-post: CCTO@mssm.edu
      • New York, New York, Forente stater, 10075
        • Rekruttering
        • Lenox Hill Hospital
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 516-734-8896
      • New York, New York, Forente stater, 10065
        • Rekruttering
        • Manhattan Eye Ear and Throat Hospital
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-434-4460
      • New York, New York, Forente stater, 10019
        • Rekruttering
        • Mount Sinai West
        • Hovedetterforsker:
          • Stephanie V. Blank
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-824-7309
          • E-post: CCTO@mssm.edu
      • Rego Park, New York, Forente stater, 11374
        • Rekruttering
        • Queens Cancer Center
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 718-312-3446
      • Rochester, New York, Forente stater, 14642
        • Rekruttering
        • University of Rochester
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 585-275-5830
        • Hovedetterforsker:
          • Rachael Turner
      • Sleepy Hollow, New York, Forente stater, 10591
        • Rekruttering
        • Phelps Memorial Hospital Center
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 914-366-1600
      • Staten Island, New York, Forente stater, 10305
        • Rekruttering
        • Staten Island University Hospital
        • Hovedetterforsker:
          • Veena S. John
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 718-226-8888
      • Stony Brook, New York, Forente stater, 11794
        • Rekruttering
        • Stony Brook University Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-862-2215
        • Hovedetterforsker:
          • Susan M. Lang
      • Syracuse, New York, Forente stater, 13210
        • Rekruttering
        • State University of New York Upstate Medical University
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 315-464-5476
        • Hovedetterforsker:
          • Mary J. Cunningham
      • The Bronx, New York, Forente stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Einstein Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nicole S. Nevadunsky
      • The Bronx, New York, Forente stater, 10467
        • Rekruttering
        • Montefiore Medical Center - Moses Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nicole S. Nevadunsky
      • The Bronx, New York, Forente stater, 10461
        • Rekruttering
        • Montefiore Medical Center-Weiler Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Nicole S. Nevadunsky
      • Uniondale, New York, Forente stater, 11553
        • Rekruttering
        • Memorial Sloan Kettering Nassau
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 212-639-7592
        • Hovedetterforsker:
          • Carol Aghajanian
      • Webster, New York, Forente stater, 14580
    • North Carolina
      • Chapel Hill, North Carolina, Forente stater, 27599
        • Rekruttering
        • UNC Lineberger Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Olivia D. Lara
      • Clinton, North Carolina, Forente stater, 28328
        • Rekruttering
        • Southeastern Medical Oncology Center-Clinton
        • Ta kontakt med:
        • Hovedetterforsker:
          • Samer S. Kasbari
      • Durham, North Carolina, Forente stater, 27710
        • Rekruttering
        • Duke University Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 888-275-3853
        • Hovedetterforsker:
          • Jennifer L. McNally
      • Goldsboro, North Carolina, Forente stater, 27534
        • Rekruttering
        • Southeastern Medical Oncology Center-Goldsboro
        • Ta kontakt med:
        • Hovedetterforsker:
          • Samer S. Kasbari
      • Jacksonville, North Carolina, Forente stater, 28546
        • Rekruttering
        • Southeastern Medical Oncology Center-Jacksonville
        • Hovedetterforsker:
          • Samer S. Kasbari
        • Ta kontakt med:
      • Raleigh, North Carolina, Forente stater, 27607
        • Rekruttering
        • Duke Women's Cancer Care Raleigh
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 919-785-4878
        • Hovedetterforsker:
          • Jennifer L. McNally
    • North Dakota
      • Fargo, North Dakota, Forente stater, 58103
        • Rekruttering
        • Essentia Health Cancer Center-South University Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
    • Ohio
      • Athens, Ohio, Forente stater, 45701
        • Rekruttering
        • OhioHealth O'Bleness Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Beachwood, Ohio, Forente stater, 44122
        • Rekruttering
        • UHHS-Chagrin Highlands Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
      • Canton, Ohio, Forente stater, 44710
        • Rekruttering
        • Aultman Health Foundation
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sunitha Vemulapalli
      • Chardon, Ohio, Forente stater, 44024
        • Rekruttering
        • Geauga Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
      • Cleveland, Ohio, Forente stater, 44106
        • Rekruttering
        • Case Western Reserve University
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
      • Columbus, Ohio, Forente stater, 43214
        • Rekruttering
        • Columbus Oncology and Hematology Associates Inc
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43214
        • Rekruttering
        • Riverside Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43215
        • Rekruttering
        • Grant Medical Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43228
        • Rekruttering
        • Doctors Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Columbus, Ohio, Forente stater, 43210
        • Rekruttering
        • Ohio State University Comprehensive Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Floor Backes
      • Delaware, Ohio, Forente stater, 43015
        • Rekruttering
        • Delaware Health Center-Grady Cancer Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Delaware, Ohio, Forente stater, 43015
        • Rekruttering
        • Grady Memorial Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Dublin, Ohio, Forente stater, 43016
        • Rekruttering
        • Columbus Oncology and Hematology Associates
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Dublin, Ohio, Forente stater, 43016
        • Rekruttering
        • Dublin Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Mansfield, Ohio, Forente stater, 44903
        • Rekruttering
        • OhioHealth Mansfield Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Marion, Ohio, Forente stater, 43302
        • Rekruttering
        • OhioHealth Marion General Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Mentor, Ohio, Forente stater, 44060
        • Rekruttering
        • UH Seidman Cancer Center at Lake Health Mentor Campus
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
      • Parma, Ohio, Forente stater, 44129
        • Rekruttering
        • University Hospitals Parma Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
      • Pickerington, Ohio, Forente stater, 43147
        • Rekruttering
        • OhioHealth Pickerington Methodist Hospital
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Sylvania, Ohio, Forente stater, 43560
        • Rekruttering
        • ProMedica Flower Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Anjalika Gandhi
      • Westerville, Ohio, Forente stater, 43082
        • Rekruttering
        • OhioHealth Westerville Medical Campus/Westerville Cancer Center
        • Hovedetterforsker:
          • Aine E. Clements
        • Ta kontakt med:
      • Westlake, Ohio, Forente stater, 44145
        • Rekruttering
        • UH Seidman Cancer Center at Saint John Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Amy Armstrong
    • Oklahoma
      • Oklahoma City, Oklahoma, Forente stater, 73104
        • Rekruttering
        • University of Oklahoma Health Sciences Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Grace Duininck
    • Oregon
      • Portland, Oregon, Forente stater, 97213
        • Rekruttering
        • Providence Portland Medical Center
        • Hovedetterforsker:
          • Dan S. Zuckerman
        • Ta kontakt med:
      • Portland, Oregon, Forente stater, 97225
        • Rekruttering
        • Providence Saint Vincent Medical Center
        • Hovedetterforsker:
          • Dan S. Zuckerman
        • Ta kontakt med:
      • Portland, Oregon, Forente stater, 97210
        • Rekruttering
        • Legacy Good Samaritan Hospital and Medical Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-220-4937
          • E-post: cancer@lhs.org
        • Hovedetterforsker:
          • Julia Fehniger
      • Tualatin, Oregon, Forente stater, 97062
        • Rekruttering
        • Legacy Meridian Park Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 503-413-1742
        • Hovedetterforsker:
          • Julia Fehniger
    • Pennsylvania
      • Erie, Pennsylvania, Forente stater, 16505
        • Rekruttering
        • UPMC Hillman Cancer Center Erie
        • Hovedetterforsker:
          • Sarah E. Taylor
        • Ta kontakt med:
      • Greensburg, Pennsylvania, Forente stater, 15601
        • Rekruttering
        • UPMC Cancer Centers - Arnold Palmer Pavilion
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 724-838-1900
        • Hovedetterforsker:
          • Sarah E. Taylor
      • Hershey, Pennsylvania, Forente stater, 17033-0850
        • Rekruttering
        • Penn State Milton S Hershey Medical Center
        • Hovedetterforsker:
          • Mark S. Shahin
        • Ta kontakt med:
      • Mechanicsburg, Pennsylvania, Forente stater, 17050
        • Rekruttering
        • UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sarah E. Taylor
      • Philadelphia, Pennsylvania, Forente stater, 19107
        • Rekruttering
        • Thomas Jefferson University Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jessa Suhner
      • Philadelphia, Pennsylvania, Forente stater, 19114
        • Rekruttering
        • Jefferson Torresdale Hospital
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jessa Suhner
      • Pittsburgh, Pennsylvania, Forente stater, 15213
        • Rekruttering
        • UPMC-Magee Womens Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 412-647-2811
        • Hovedetterforsker:
          • Sarah E. Taylor
      • Pittsburgh, Pennsylvania, Forente stater, 15237
        • Rekruttering
        • UPMC-Passavant Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 412-367-6454
        • Hovedetterforsker:
          • Sarah E. Taylor
      • Washington, Pennsylvania, Forente stater, 15301
        • Rekruttering
        • UPMC Cancer Center-Washington
        • Ta kontakt med:
        • Hovedetterforsker:
          • Sarah E. Taylor
      • Willow Grove, Pennsylvania, Forente stater, 19090
        • Rekruttering
        • Asplundh Cancer Pavilion
        • Ta kontakt med:
        • Hovedetterforsker:
          • Jessa Suhner
    • Rhode Island
      • Providence, Rhode Island, Forente stater, 02903
        • Rekruttering
        • Rhode Island Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 401-444-1488
        • Hovedetterforsker:
          • Boris Martinez
      • Providence, Rhode Island, Forente stater, 02905
        • Rekruttering
        • Women and Infants Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 401-274-1122
        • Hovedetterforsker:
          • Paul A. DiSilvestro
    • Tennessee
      • Franklin, Tennessee, Forente stater, 37067
        • Rekruttering
        • Vanderbilt-Ingram Cancer Center Cool Springs
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Hovedetterforsker:
          • Alaina J. Brown
      • Nashville, Tennessee, Forente stater, 37232
        • Rekruttering
        • Vanderbilt University/Ingram Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Hovedetterforsker:
          • Alaina J. Brown
      • Nashville, Tennessee, Forente stater, 37204
        • Rekruttering
        • Vanderbilt Breast Center at One Hundred Oaks
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-811-8480
        • Hovedetterforsker:
          • Alaina J. Brown
    • Utah
      • Salt Lake City, Utah, Forente stater, 84106
        • Rekruttering
        • University of Utah Sugarhouse Health Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Talicia Savage
      • Salt Lake City, Utah, Forente stater, 84112
        • Rekruttering
        • Huntsman Cancer Institute/University of Utah
        • Ta kontakt med:
        • Hovedetterforsker:
          • Talicia Savage
      • South Jordan, Utah, Forente stater, 84009
        • Rekruttering
        • South Jordan Health Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Talicia Savage
    • Virginia
      • Charlottesville, Virginia, Forente stater, 22908
        • Rekruttering
        • University of Virginia Cancer Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Matthew K. Wagar
      • Richmond, Virginia, Forente stater, 23298
        • Rekruttering
        • VCU Massey Comprehensive Cancer Center
        • Hovedetterforsker:
          • Jaclyn Wall
        • Ta kontakt med:
    • Washington
      • Edmonds, Washington, Forente stater, 98026
        • Rekruttering
        • Swedish Cancer Institute-Edmonds
        • Hovedetterforsker:
          • Dan S. Zuckerman
        • Ta kontakt med:
      • Issaquah, Washington, Forente stater, 98029
        • Rekruttering
        • Swedish Cancer Institute-Issaquah
        • Hovedetterforsker:
          • Dan S. Zuckerman
        • Ta kontakt med:
      • Seattle, Washington, Forente stater, 98122
        • Rekruttering
        • Swedish Medical Center-First Hill
        • Hovedetterforsker:
          • Dan S. Zuckerman
        • Ta kontakt med:
      • Seattle, Washington, Forente stater, 98195
        • Rekruttering
        • University of Washington Medical Center - Montlake
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-804-8824
        • Hovedetterforsker:
          • Heidi J. Gray
      • Seattle, Washington, Forente stater, 98109
        • Rekruttering
        • Fred Hutchinson Cancer Center
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 800-804-8824
        • Hovedetterforsker:
          • Heidi J. Gray
      • Vancouver, Washington, Forente stater, 98686
        • Rekruttering
        • Legacy Salmon Creek Hospital
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 503-413-2150
        • Hovedetterforsker:
          • Julia Fehniger
    • West Virginia
      • Bridgeport, West Virginia, Forente stater, 26330
        • Rekruttering
        • United Hospital Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Krista S. Pfaendler
      • Charleston, West Virginia, Forente stater, 25304
        • Rekruttering
        • Vandalia Health/CAMC Institute for Academic Medicine
        • Hovedetterforsker:
          • Stephen H. Bush
        • Ta kontakt med:
      • Martinsburg, West Virginia, Forente stater, 25401
        • Rekruttering
        • WVUH-Berkely Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Krista S. Pfaendler
      • Morgantown, West Virginia, Forente stater, 26506
        • Rekruttering
        • West Virginia University Healthcare
        • Ta kontakt med:
        • Hovedetterforsker:
          • Krista S. Pfaendler
      • Parkersburg, West Virginia, Forente stater, 26101
        • Rekruttering
        • Camden Clark Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Krista S. Pfaendler
    • Wisconsin
      • Ashland, Wisconsin, Forente stater, 54806
        • Rekruttering
        • Duluth Clinic Ashland
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Green Bay, Wisconsin, Forente stater, 54301
        • Rekruttering
        • Saint Vincent Hospital Cancer Center Green Bay
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Green Bay, Wisconsin, Forente stater, 54303
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • La Crosse, Wisconsin, Forente stater, 54601
        • Rekruttering
        • Gundersen Lutheran Medical Center
        • Ta kontakt med:
        • Hovedetterforsker:
          • Gil Harmon
      • Milwaukee, Wisconsin, Forente stater, 53226
        • Rekruttering
        • Medical College of Wisconsin
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 414-805-3666
        • Hovedetterforsker:
          • William H. Bradley
      • Oconto Falls, Wisconsin, Forente stater, 54154
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Sheboygan, Wisconsin, Forente stater, 53081
        • Rekruttering
        • Sheboygan Physicians Group
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Spooner, Wisconsin, Forente stater, 54801
        • Rekruttering
        • Essentia Health-Spooner Clinic
        • Ta kontakt med:
        • Hovedetterforsker:
          • Bret E. Friday
      • Sturgeon Bay, Wisconsin, Forente stater, 54235-1495
        • Rekruttering
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Hovedetterforsker:
          • Matthew L. Ryan
        • Ta kontakt med:
      • Superior, Wisconsin, Forente stater, 54880
        • Rekruttering
        • Essentia Health Saint Mary's Hospital - Superior
        • Hovedetterforsker:
          • Bret E. Friday
        • Ta kontakt med:
          • Site Public Contact
          • Telefonnummer: 701-364-6272

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Beskrivelse

Inclusion Criteria:

  • Documentation of disease:

    • Stage III and stage IVA endometrial cancers (with measurable disease),
    • Stage IVB endometrial cancer (with or without measurable disease), or
    • Recurrent endometrial cancer (with or without measurable disease)
  • In patients with measurable disease, lesions will be defined and monitored by RECIST 1.1. Measurable disease (RECIST 1.1) is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be ≥ 10 mm when measured by CT or MRI. Lymph nodes must be ≥ 15 mm in short axis when measured by CT or MRI

  • Histologic confirmation of the original primary tumor is required (submission of pathology report[s] is required). Patients with the following histologic types are eligible: endometrioid, serous, dedifferentiated/undifferentiated, clear cell, mixed epithelial, carcinosarcoma, adenocarcinoma not otherwise specified (N.O.S.)

  • Patients must have:

    • Tumoral mismatch repair proficient (pMMR) disease as assessed by immunohistochemistry (IHC) AND
    • P53 IHC with aberrant staining pattern (aberrant p53 expression is consistent with mutant TP53). TP53 mutation by next-generation sequencing will also be accepted
  • A pathology report demonstrating results of institutional MMR IHC and p53 IHC and/or TP53 by next-generation sequencing

  • Patients may have received:

    • NO prior chemotherapy for treatment of endometrial cancer OR
    • Prior adjuvant chemotherapy (e.g., paclitaxel/carboplatin alone or as a component of concurrent chemotherapy and radiation therapy [with or without cisplatin]) provided adjuvant chemotherapy was completed ≥ 12 months prior to registration
  • Patients may have received prior radiation therapy for treatment of endometrial cancer. Prior radiation therapy may have included pelvic radiation therapy, extended field pelvic/para-aortic radiation therapy, intravaginal brachytherapy, and/or palliative radiation therapy. All radiation therapy must be completed at least 4 weeks prior to registration. For patients with recent radiation, they must have RECIST-evaluable disease outside of the radiation field and have recovered their marrow function

  • Patients may have received prior hormonal (endocrine) therapy. All hormonal (endocrine) therapy must have been completed at least 1 week prior to registration

  • NO prior pembrolizumab (or other anti-PD1, anti-PDL1 or anti-CTLA4 therapy) or bevacizumab (or other antiangiogenic therapy)

  • Interval or cytoreductive surgery, after start of treatment on this trial, and prior to documentation of disease progression, is NOT permitted

  • Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of disease progression. Patients with brain metastases must have follow up imaging demonstrating no evidence of disease progression and that the disease is stable off of steroids

  • Age ≥ 18

  • Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2

  • Not pregnant and not nursing

  • Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3

  • Platelets ≥ 100,000 cells/mm^3

  • Hemoglobin ≥ 8 g/dl

  • Creatinine clearance (CrCl) of ≥ 30 mL/min by the Cockcroft-Gault formula

  • Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x institutional ULN may be enrolled)

  • Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x institutional ULN

  • Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class II or better

  • No active infection requiring parenteral antibiotics

  • No current evidence of intra-abdominal abscess, abdominal/pelvic fistula (not diverted), gastrointestinal perforation, gastrointestinal (GI) obstruction, and/or need for drainage nasogastric or gastrostomy tube

  • No clinically significant bleeding within 28 days prior to registration

  • No uncontrolled hypertension, defined as systolic ≥ 160 mm Hg or diastolic ≥ 100 mm Hg

  • No major surgery within 28 days of initiation of bevacizumab

  • No active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease

    • Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible
    • Topical or inhaled steroids are allowed
    • Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), and anti-thyroid antibodies should be evaluated with the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible
  • No history of (non-infectious) pneumonitis that required steroids, or current pneumonitis

  • No history of stem cell or solid organ transplant

  • No history of allergic reaction to the study agent(s) or compounds of similar chemical or biologic composition to the study agent(s) (or any of its excipients)

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Arm 1 (paclitaxel, carboplatin, pembrolizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional 14 cycles. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navn:
  • Blastokarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Karboplatina
  • Karbosin
  • Karbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatinum
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navn:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Given IV

Andre navn:
  • Keytruda
  • MK-3475
  • Lambrolizumab
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumab Biosimilar BCD-201
  • Pembrolizumab Biosimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumab Biosimilar GME751
  • MK 3475
  • SCH900475
  • Pembrolizumab Biosimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab Biosimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo urine and blood sample collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: Arm 2 (paclitaxel, carboplatin, bevacizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navn:
  • Blastokarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Karboplatina
  • Karbosin
  • Karbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatinum
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navn:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Given IV

Andre navn:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humanisert monoklonalt antistoff
  • Anti-VEGF monoklonalt antistoff SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Immunoglobulin G1 (Human-mus monoklonal rhuMab-VEGF Gamma-kjede anti-human vaskulær endotelial vekstfaktor), disulfid med human-mus monoklonal rhuMab-VEGF lett kjede, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinant humanisert anti-VEGF monoklonalt antistoff
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-equi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • CT P16
  • CTP16
  • Likestilt
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Undergo urine and blood sample collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling
Eksperimentell: Arm 3 (paclitaxel, carboplatin, pembrolizumab, bevacizumab)

Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.

Given IV

Andre navn:
  • Blastokarb
  • Carboplat
  • Carboplatin Hexal
  • Carboplatino
  • Karboplatina
  • Karbosin
  • Karbosol
  • Carbotec
  • CBDCA
  • Displata
  • Ercar
  • JM-8
  • Nealorin
  • Novoplatinum
  • Paraplatin
  • Paraplatin AQ
  • Platinwas
  • Ribocarbo
  • JM8

Given IV

Andre navn:
  • Taxol
  • Anzatax
  • Asotax
  • Bristaxol
  • Praxel
  • Taxol Konzentrat

Given IV

Andre navn:
  • Avastin
  • ABP 215
  • Anti-VEGF
  • Anti-VEGF humanisert monoklonalt antistoff
  • Anti-VEGF monoklonalt antistoff SIBP04
  • Anti-VEGF rhuMAb
  • Bevacizumab awwb
  • Bevacizumab Biosimilar ABP 215
  • Bevacizumab Biosimilar BEVZ92
  • Bevacizumab Biosimilar BI 695502
  • Bevacizumab Biosimilar CBT 124
  • Bevacizumab Biosimilar CT-P16
  • Bevacizumab Biosimilar FKB238
  • Bevacizumab Biosimilar GB-222
  • Bevacizumab Biosimilar HD204
  • Bevacizumab Biosimilar HLX04
  • Bevacizumab Biosimilar IBI305
  • Bevacizumab Biosimilar LY01008
  • Bevacizumab Biosimilar MIL60
  • Bevacizumab Biosimilar Mvasi
  • Bevacizumab Biosimilar MYL-1402O
  • Bevacizumab Biosimilar QL 1101
  • Bevacizumab Biosimilar RPH-001
  • Bevacizumab Biosimilar SCT501
  • Bevacizumab Biosimilar Zirabev
  • Bevacizumab-awwb
  • Bevacizumab-bvzr
  • BP102
  • BP102 Biosimilar
  • HD204
  • Immunoglobulin G1 (Human-mus monoklonal rhuMab-VEGF Gamma-kjede anti-human vaskulær endotelial vekstfaktor), disulfid med human-mus monoklonal rhuMab-VEGF lett kjede, dimer
  • Mvasi
  • MYL-1402O
  • Rekombinant humanisert anti-VEGF monoklonalt antistoff
  • rhuMab-VEGF
  • SCT501
  • SIBP 04
  • SIBP-04
  • SIBP04
  • Zirabev
  • Avegra
  • QL1101
  • IBI305
  • Byvasda
  • Bevacizumab Biosimilar QL1101
  • BAT1706
  • BAT 1706
  • BAT-1706
  • BAT1706 Biosimilar
  • Bevacizumab Biosimilar BAT1706
  • Bevacizumab-adcd
  • CT-P16
  • Vegzelma
  • Alymsys
  • ABP-215
  • ABP215
  • Aybintio
  • Bevacizumab-aybi
  • Bevacizumab-equi
  • Bevacizumab-maly
  • Bevacizumab-onbe
  • CT P16
  • CTP16
  • Likestilt
  • Onbevzi
  • Avzivi
  • Bevacizumab Biosimilar MB02
  • Bevacizumab-tnjn
  • FKB 238
  • FKB-238
  • FKB238
  • MB 02
  • MB-02
  • MB02
  • Oyavas
  • PF 06439535
  • PF-06439535
  • PF06439535
  • Bevacizumab-aveg
  • Bevacizumab-byva
  • Bevacizumab-nwgd
  • Jobevne
  • IBI 305
  • IBI-305

Undergo CT

Andre navn:
  • CT
  • KATT
  • CAT-skanning
  • Beregnet aksial tomografi
  • Datastyrt aksialtomografi
  • Datastyrt tomografi
  • CT skann
  • tomografi
  • Datastyrt aksial tomografi (prosedyre)
  • Datastyrt tomografi (CT) skanning
  • Diagnostisk CAT -skanning
  • Diagnostisk CAT -skannertype

Undergo MRI

Andre navn:
  • MR
  • Magnetisk resonans
  • Magnetic Resonance Imaging Scan
  • Medisinsk bildebehandling, magnetisk resonans / kjernemagnetisk resonans
  • MR Imaging
  • MR-skanning
  • NMR-avbildning
  • NMRI
  • Kjernemagnetisk resonansavbildning
  • Magnetisk resonanstomografi (MR)
  • sMRI
  • Magnetisk resonansavbildning (prosedyre)
  • MR-er
  • Strukturell MR

Given IV

Andre navn:
  • Keytruda
  • MK-3475
  • Lambrolizumab
  • SCH 900475
  • MK3475
  • SCH-900475
  • BCD-201
  • Pembrolizumab Biosimilar BCD-201
  • Pembrolizumab Biosimilar QL2107
  • QL2107
  • GME 751
  • GME751
  • Pembrolizumab Biosimilar GME751
  • MK 3475
  • SCH900475
  • Pembrolizumab Biosimilar RPH-075
  • RPH 075
  • RPH-075
  • RPH075
  • Pembrolizumab Biosimilar SB27
  • SB 27
  • SB-27
  • SB27

Undergo urine and blood sample collection

Andre navn:
  • Biologisk prøvesamling
  • Bioprøve samlet
  • Prøvesamling

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Progression-free survival (PFS)
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will be defined using Response Evaluation Criteria in Solid Tumors version (v) 1.1. Will be tested using one-sided log-rank tests with α-levels stratified by factors used in the randomization. Patients will be grouped by their randomized treatment assignment for intention-to-treat (ITT) analyses, supported by patients in ITT population. Treatment hazard ratios and their 95% confidence intervals will be estimated using a Cox proportional hazards models specified with a main effect for the randomized treatment assignment and stratified using the stratification factors applied at randomization.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Overall survival (OS)
Tidsramme: From study entry to time of death from any cause, assessed up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for treatment (with Arm 1 as the reference arm).

From study entry to time of death from any cause, assessed up to 5 years
Prognostic and predictive associations of type of TP53 mutation status with PFS
Tidsramme: Up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups.

Up to 5 years
Prognostic and predictive associations of type of TP53 mutation status with OS
Tidsramme: Up to 5 years

Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups.

Up to 5 years
Incidence of adverse events (AEs) in treatment with bevacizumab when combined with carboplatin, paclitaxel, and pembrolizumab
Tidsramme: Up to 90 days after last dose of study treatment

The nature, frequency, and degree of toxicity will be tabulated at the system organ class and AE-specific term levels using Common Terminology Criteria for Adverse Events v 5.0. Each patient will be represented according to maximum grade observed for each term. Tabulations will show the number and percentage of patients by maximum grade, within the treatment group received, regardless of the randomized treatment assignment. No specific hypothesis test is pre-specified.

Up to 90 days after last dose of study treatment
Objective response rate
Tidsramme: Within 12 months of initiating therapy

Will be defined as the binomial proportion of evaluable patients with a best overall response of complete response or partial response. Will be supported by their 2-sided, 95% Wilson-Score confidence intervals. The relative odds of response in each experimental group (vs the reference group) will be estimated using a multivariable logistic regression model specified with main effects for the treatment groups and stratified by the stratification factors reported at baseline.

Within 12 months of initiating therapy

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by sex.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by race.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
PFS
Tidsramme: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by ethnicity.

From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Amanda N Fader, NRG Oncology

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

27. januar 2026

Primær fullføring (Antatt)

1. juli 2028

Studiet fullført (Antatt)

1. juli 2028

Datoer for studieregistrering

Først innsendt

27. september 2025

Først innsendt som oppfylte QC-kriteriene

27. september 2025

Først lagt ut (Faktiske)

30. september 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. november 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-planbeskrivelse

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Ja

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

produkt produsert i og eksportert fra USA

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere